ChoiceSpine received FDA 510(k) clearance to market the HAWKEYE™ Ti 3D-printed titanium vertebral body replacement for use in the cervical spine, thus opening its use to all three spinal segments: cervical, thoracic and lumbar. Expansion of commercial launch will continue through 2Q19.
The HAWKEYE portfolio includes devices in a small or medium size footprint ranging from 14 mm to 60 mm in height, with a built-in 0° or 8° of lordosis. A large center chamber accepts bone graft, and lateral windows allow surgeons to assess spinal fusion over time.
ChoiceSpine received FDA 510(k) clearance to market the HAWKEYE™ Ti 3D-printed titanium vertebral body replacement for use in the cervical spine, thus opening its use to all three spinal segments: cervical, thoracic and lumbar. Expansion of commercial launch will continue through 2Q19.
The HAWKEYE portfolio includes devices in a small or...
ChoiceSpine received FDA 510(k) clearance to market the HAWKEYE™ Ti 3D-printed titanium vertebral body replacement for use in the cervical spine, thus opening its use to all three spinal segments: cervical, thoracic and lumbar. Expansion of commercial launch will continue through 2Q19.
The HAWKEYE portfolio includes devices in a small or medium size footprint ranging from 14 mm to 60 mm in height, with a built-in 0° or 8° of lordosis. A large center chamber accepts bone graft, and lateral windows allow surgeons to assess spinal fusion over time.
Copy to clipboard 
